| This new issue contains the following articles: Research Articles Reliability and validity of the London Chest Activity of Daily Living scale for adults with asthma Vitória Cavalheiro Puzzi, MSc, Joice Mara de Oliveira, MSc, Thainá Bessa Alves, MSc, Jessica Priscila da Conceição Silva, MSc, Ariele Pedroso, MSc & Karina Couto Furlanetto, PhD Pages: 1-9 | DOI: 10.1080/02770903.2023.2234990 Establishment of a homogeneous chemiluminescence immunoassay for cat dander sIgE antibody detection Yuanmin Sun, MS, Ren Na, PhD, Lina Zhu, MS, Xiaohui Yang, MS, Xin Tan, MS, Lisheng Zheng, MS, Huiqiang Li, MS & Yang Yu, PhD Pages: 10-19 | DOI: 10.1080/02770903.2023.2234994 Doxycycline may be more clinically effective in type 2 chronic rhinosinusitis nasal polyp comorbid with asthma Gülden Paçacı Çetin, MD, Bahar Arslan, MD & İnsu Yılmaz, MD Pages: 20-26 | DOI: 10.1080/02770903.2023.2236696 A cross-sectional study to evaluate utility measure and health-related quality of life (HRQoL) among patients with severe uncontrolled asthma in Spain |  Eva Martínez Moragón, MD, Luis Manuel Entrenas Costa, MD, Joaquín Sánchez-Covisa Hernández, MSc, Anna de Prado Moncusí, MSc & Gema Monteagudo Ruiz, MSc Pages: 27-38 | DOI: 10.1080/02770903.2023.2241891 Cost-effectiveness and resource use analysis of patients with asthma before and after treatment with mepolizumab in a real-life setting Javier Domínguez-Ortega, MD, PhD, Daniel Laorden, MD, Francisca Vílchez-Sánchez, MD, David Bañas-Conejero, MSc & Santiago Quirce, MD, PhD Pages: 39-47 | DOI: 10.1080/02770903.2023.2241905 Serum levels of interleukin-33, soluble ST2 and IgE in patients with asthma: a case-control study Himadri Singh, M.Sc, Alkesh Khurana, MD, Ashok Kumar, PhD & Rohit Saluja, PhD Pages: 48-57 | DOI: 10.1080/02770903.2023.2244579 Assessment of lifestyle and coping strategies among asthmatic patients during the Covid-19 crisis Eshrak Hashem, BSN, MSc, PhD, Faten Kandil, BSN, MSc, PhD, Fatmah Alsharif, BSN, RN, MSc, PhD, Loujain Sharif, BSN, MSc, PhD & Asmaa Khaled, BSN, MSc, PhD Pages: 58-68 | DOI: 10.1080/02770903.2023.2272790 Case Reports Long-term use of mepolizumab in a case of chronic eosinophilic pneumonia: extending interval dosing Alicia Prieto-García, MD, PhD, María Isabel Peligros, MD, Isabel Pérez Tamayo, MD, José Manuel Zubeldia, MD, PhD, Luis Álvarez-Sala, MD, PhD & Cristina Lavilla, MD Pages: 69-71 | DOI: 10.1080/02770903.2023.2239343 “Patient remodeling” as a consequence of uncontrolled and prolonged OCS use in severe asthma: how biologic therapy can reverse a dangerous trend Margherita Perlato, MD, Valentina Mecheri, MD, Emanuele Vivarelli, MD, Matteo Accinno, BSc, Alessandra Vultaggio, MD, PhD & Andrea Matucci, MD Pages: 72-75 | DOI: 10.1080/02770903.2023.2241910 Letter to the Editor The impact of psychological health in African American young adults on asthma control: why is phenotyping still an unmet need? Suggestions from a multidisciplinary ‘Stress-Asthma Working Group’ Gennaro Liccardi, MD, Matteo Martini, MD, Maria Beatrice Bilò, MD, Manlio Milanese, MD, Ilaria Baiardini, PhD, Maria Vittoria Liccardi, PhD & Paola Rogliani, MD Pages: 76-79 | DOI: 10.1080/02770903.2023.2236704 |